
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BAVA | Copenhagen | DKK | Real-time | |
BAVAc | BATS Europe | DKK | Delayed | |
BVNRY | OTC Markets | USD | Delayed | |
BAVA | Frankfurt | EUR | Delayed | |
BAVA | Vienna | EUR | Real-time |
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Luc Debruyne | 61 | 2022 | Independent Chairman |
Franciscus A. G. M. Verwiel | 63 | 2015 | Independent Director |
Anne Louise Eberhard | 62 | 2019 | Independent Director |
Johan Van Hoof | 68 | 2023 | Independent Director |
Christina Teichert | - | 2025 | Employee-Elected Member of the Board |
Mette Boas Schwartzlose | - | 2025 | Employee-Elected Member of the Board |
Montse Montaner Picart | 57 | 2023 | Independent Director |
Anja Gjol | 45 | 2021 | Employee-Elected Member of the Board |
Heidi Hunter | 67 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review